Under the Horizon Europe research and innovation programme comes a new European Partnership for Personalised Medicine (EP Per MED) call “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine” or MultiPMData2026.
Opening date: 1 October 2025
Deadline for submission of pre-proposals: 12 January 2026
The integration of personalised medicine into European healthcare systems holds great potential but also presents significant challenges. Although countries across the EU have made substantial progress in areas such as advanced diagnostics, innovative treatment modalities, and digital health technologies including artificial intelligence, the widespread adoption of these innovations remains limited. Test and demonstration environments serve as enablers bridging this gap. These controlled yet realistic settings enable healthcare providers, innovators, researchers and patients to evaluate and refine new solutions under controlled real-world conditions, increasing the chances of innovations reaching end-users and a broader implementation as well as ensuring equal access to these innovative healthcare services.
Multimorbidity is a major and growing global concern, affecting 20–40% of middle-aged adults and up to 80% of older adults. Combinations of multiple chronic disorders present great challenges for healthcare professionals, place a substantial economic burden on society, and significantly reduce the quality of life for patients and families. Further, multimorbid conditions require holistic approaches for optimal care, which is very challenging to many secondary healthcare settings that are specialised towards single-condition cases.
Managing chronic diseases and multimorbidity presents several challenges. Patients often depend on healthcare systems for extended periods, leading to high societal costs and reduced quality of life. Disease progression can be unpredictable, with relapses and remissions complicating management. Diagnosing and treating multiple conditions simultaneously adds complexity, as combined treatment regimens can result in drug interactions and other harmful side effects. Additionally, patients may struggle to adhere to long-term therapies. Further, a lack of synergy between care providers further exacerbates these issues, with sub-optimal use of health data hindering effective care coordination. Developing more personalised approaches through the integration of multimodal health data from multiple sources holds great potential to address the complex challenges of managing chronic disease and multimorbidity. To fully leverage this potential, there is an urgent need to find more efficient ways to utilise multimodal health data to support clinical decision-making, improve disease management and empower patients as active participants in their own care.
MultiPMData2026 is co-funded by 19 organisations in various EU Member States.
Link to the electronic proposal submission tool
For further information, please visit the EP Per MED website or see the PDF below.